Leerink an­a­lyst ad­justs nusin­ersen peak to $2.5B; Dai­ichi Sankyo signs up to work with Dana-Far­ber team

Count Ge­of­frey Porges in the mix of an­a­lysts cheer­ing Io­n­is $IONS and Bio­gen $BI­IB for­ward on fresh ev­i­dence of the ef­fi­ca­cy of nusin­ersen for spinal …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA